Also trades as: RGBP (OTC) · $vol 0M
RGBPP OTC
Regen BioPharma, Inc.
1W: -49.0%
1M: -51.6%
3M: -70.0%
YTD: -91.7%
1Y: -98.3%
3Y: -99.9%
5Y: -100.0%
$0.00
-0.00 (-21.05%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0011-0.095
Volume2,476,903
Avg Volume275,560
Beta-0.24
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODavid Raymond Koos
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2016-04-20
Websiteregenbiopharmainc.com
8697 La Mesa Boulevard
La Mesa, CA 91942
US
La Mesa, CA 91942
US
619 722 5505
About Regen BioPharma, Inc.
Regen BioPharma, Inc. is dedicated to advancing regenerative medicine solutions across the United States. The company's scientific endeavors involve identifying small molecules that modulate NR2F6, with the aim of either stimulating immune cells for cancer treatments or suppressing them for managing autoimmune conditions. Currently, its product pipeline and therapeutic approaches are in nascent developmental phases. Established in 2012, Regen BioPharma, Inc. operates from its headquarters in La Mesa, California.
Latest News
No recent news
Recent Insider Trades
No insider trades found